Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Gastroenterology
•
General Gastroenterology
What inpatient diagnostic workup do you pursue in a patient with an unspecified vomiting disorder who cannot be discharged due to poor PO tolerance?
How do you balance pursuing a thorough and timely workup while avoiding unnecessary testing?
Related Questions
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
How do you counsel a patient on returning to the care of their PCP when a workup for MCAS has been unrevealing, but the patient insists that they have a mast cell disorder because they respond to antihistamine therapy?
What factors guide your choice of hot snare polypectomy vs cold snare polypectomy for non-pedunculated colonic polyps between 10-20 mm in size and those greater than 20 mm in size?
How would you approach management of a patient with a medium-to-large vessel vasculitis who developed perforation of the stomach and colon on steroids and cyclophosphamide?
Which colonic polyp or mass-like lesions do you refer to an advanced endoscopist?
Has your institution and/or antimicrobial stewardship program incorporated a selective antibiotic approach to treatment of left-sided uncomplicated diverticulitis in immunocompetent patients?
What sampling techniques do you use to improve the diagnostic yield of biopsies in a patient with suspected vasculitis and extensive scattered ulceration throughout the GI tract?
What is your approach to treatment of patients with fulminant C difficile infection who required ileostomy creation or colectomy?
What is your approach to duration of fidaxomicin in a patient receiving treatment for first C difficile infection while also receiving concurrent antibiotics for an infection?
Under what circumstances would you recommend early fecal microbiota transplantation over antibiotic treatment or bezlotoxumab in a patient with recurrent C. difficile infection?